---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-006426"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2022-04-28T23:59:59+00:00"
generated_at: "2026-06-26T03:48:11.499524+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Mednax Q1 GAAP loss $0.25/sh includes $57M debt charge; adj EPS $0.33

## Summary
- Revenue $482M (+8% YoY); same-unit revenue +1.3%, volume +3.2%.
- GAAP loss from continuing ops $20.9M ($0.25/sh) vs income $5.4M ($0.06/sh) prior year.
- Adjusted EPS $0.33 vs $0.24 prior year; Adjusted EBITDA $50.7M vs $45.5M.
- Issued $400M 5.375% notes due 2030; redeemed $1.0B 6.25% notes due 2027, causing $57M loss.
- Cash from ops used $89.9M; total debt $799M at quarter end.

## SEC filing metadata
- accession: 0000950170-22-006426
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2022-04-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017022006426/0000950170-22-006426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017022006426/md-20220428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-006426
- JSON: https://secwatch.observer/filing/0000950170-22-006426.json
- Plain text: https://secwatch.observer/filing/0000950170-22-006426.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.